CAS 232605-26-4

(3aS,6aS)-5-Methylene-6a-(naphthalen-2-ylmethyl)perhydrocyclopenta[c]furan-1-one

Description:

The chemical substance known as (3aS,6aS)-5-Methylene-6a-(naphthalen-2-ylmethyl)perhydrocyclopenta[c]furan-1-one, with the CAS number 232605-26-4, is a complex organic compound characterized by its unique bicyclic structure. This compound features a perhydrocyclopenta[c]furan core, which is a saturated cyclic structure, and is substituted with a methylene group and a naphthalen-2-ylmethyl moiety. The stereochemistry indicated by the (3aS,6aS) configuration suggests specific spatial arrangements of the substituents, which can influence the compound's reactivity and interactions. Typically, compounds of this nature may exhibit interesting biological activities or serve as intermediates in synthetic organic chemistry. The presence of the naphthalene ring may contribute to aromatic properties, potentially affecting solubility and stability. Overall, the characteristics of this compound make it a subject of interest in fields such as medicinal chemistry and materials science, where understanding its properties can lead to the development of new applications or therapeutic agents.

Formula: C₁₉H₁₈O₂

InChI: InChI=1/C19H18O2/c1-13-8-17-12-21-18(20)19(17,10-13)11-14-6-7-15-4-2-3-5-16(15)9-14/h2-7,9,17H,1,8,10-12H2/t17-,19+/m1/s1

Synonyms:

• Bay-36-7620
• (3aS,6aS)-5-methylidene-6a-(naphthalen-2-ylmethyl)hexahydro-1H-cyclopenta[c]furan-1-one
• (3aS,6aS)-Hexahydro-5-methylene-6a-(2-naphthalenylmethyl)-1H-cyclopenta[c]furan-1-one
• (3aS,6aS)-5-methylidene-3a-(naphthalen-2-ylmethyl)-1,4,6,6a-tetrahydrocyclopenta[c]furan-3-one
• 1H-Cyclopenta[c]furan-1-one, hexahydro-5-methylene-6a-(2-naphthalenylmethyl)-, (3aS,6aS)-

BAY 36-7620

CAS: 232605-26-4

BAY 36-7620 is a small molecule inhibitor of glial glutamate receptor type 1 (GluR1). It has been shown to reduce the viability of cancer cells in a dose-dependent manner. BAY 36-7620 has also been found to induce neuroprotection in rodent models of Parkinson's disease by inhibiting the expression and phosphorylation of GluR1 at serine 845. This inhibition prevents the activation of GluR1 receptors, which may lead to cell death. BAY 36-7620 also inhibits the activation of purinergic receptors and decreases aerobic glycolysis in cancer cells, which may lead to tumor shrinkage.

Formula: C₁₉H₁₈O₂

Purity: Min. 95%

Molecular weight: 278.3 g/mol

Ref: 3D-HJA60526